%0 Journal Article %T 瘤内注药治疗晚期肺癌的研究进展
Research Progress of Intratumoral Medication Injection in the Treatment of Advanced Lung Cancer %A 钱晓玲 %A 郭欢 %A 戴辉 %A 段雪琴 %A 黄席羽 %A 邓祎铃 %A 黄蕊 %A 封晓东 %A 张培先 %J Advances in Clinical Medicine %P 8231-8238 %@ 2161-8720 %D 2023 %I Hans Publishing %R 10.12677/ACM.2023.1351152 %X 目前肺癌是我国死亡率最高的恶性肿瘤。随着微创技术的发展,近年来应用微创介入疗法在晚期肺癌局部治疗中的应用越来越广泛,也由于其安全有效,在肿瘤综合治疗中成为重要组成部分。瘤内注药术是一种微创治疗方法,已经广泛应用于肝恶性肿瘤的治疗,其安全性高、治疗费用少、局部肿瘤控制有效,也有部分研究将其用于晚期肺癌局部治疗,该文对近年来瘤内注药治疗晚期肺癌的研究进展作一文献综述,拟为晚期肺癌的微创治疗提供新的有效的方法。
The malignant tumor with the greatest fatality rate right now in China is lung cancer. Due to its safety and effectiveness, the use of minimally invasive interventional therapies in the local treat-ment of advanced lung cancer has grown significantly in recent years with the development of these techniques. It has also become a significant part of the all-encompassing treatment of tumors. In-tratumoral medication injection is a minimally invasive treatment method that has been widely used in the treatment of liver malignancies. It is highly safe, cost-effective, and effectively controls local tumor growth. Some studies have also explored its potential use in the local treatment of ad-vanced lung cancer. This paper provides a literature review of recent research progress in intra-tumoral medication injection for the treatment of advanced lung cancer and offers a new and effec-tive method for minimally invasive treatment of advanced lung cancer. %K 瘤内注药,晚期肺癌,免疫,治疗,研究进展
Intratumoral Drug Injection %K Advanced Lung Cancer %K Immunology %K Treatment %K Research Progress %U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=65738